Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke [Basic Sciences]

Conclusions—Our results suggest that MAGL may contribute to the pathophysiology of focal cerebral ischemia and is thus a promising therapeutic target for the treatment of ischemic stroke.

Source: Stroke - February 26, 2018 Category: Neurology Authors: Sang-Ho Choi, Allison L. Arai, Yongshan Mou, Byeongteck Kang, Cecil Chern-Chyi Yen, John Hallenbeck, Afonso C. Silva Tags: Animal Models of Human Disease, Basic Science Research, Inflammation, Ischemic Stroke Original Contributions Source Type: research